Search results
Mapping the 3D genome in rare immune cells reveals new genes linked with autoimmune disease risk
August 4th, 2026
Our DNA is often pictured as a simple spiral, like a piece of rope held taut. But inside cells, it folds into a complex three-dimensional structure, w...
LMS Director speaks at opening of Pfizer’s new London research centre
July 31st, 2026
Wiebke, who is also Professor of Transdisciplinary Medicine at Imperial College London alongside her role as Director of the MRC LMS, spoke this week ...
Scientists map dormant cancer cells’ hideouts, opening new targets for treatment
July 30th, 2026
The landscape of a tumour is diverse. Nestled among the frantically dividing cells are immune cells, newly-formed blood vessels, and a class of suspic...
Scientists pinpoint where cells first begin copying DNA
July 23rd, 2026
Every time a cell divides, it must faithfully copy its entire genetic instruction manual. Errors during this process can damage the genome, making DNA...
Dr CK Wong joins the LMS as Head of the Endocrine Signalling in Inflammation Group
July 17th, 2026
Chronic inflammation plays a central role in many diseases, damaging vital organs and worsening inflammation throughout the body. Medicines based on t...
Imperial cancer therapy spinout and LMS collaborator Myricx Bio agrees to be acquired by Novartis
July 9th, 2026
Myricx Bio is focused on the discovery and development of new treatments for a range of different tumour types through a novel class of payloads for a...
UK’s world-class research organisations launch new collective with LMS as a proud member
July 9th, 2026
Scientific breakthroughs don't happen in isolation. National research institutes like the LMS provide the long-term expertise, specialist facilities a...
Dr Lara Curran awarded BHF Fellowship for research into inherited heart condition
June 18th, 2026
Hypertrophic cardiomyopathy (HCM) affects approximately 1 in 500 people and is a leading cause of inherited heart disease. The condition is characteri...
